What does GCE mean in HEALTHCARE

The primary cause of glycine encephalopathy is a genetic mutation in the GLDC gene which encodes for the production of an enzyme called glycine decarboxylase. This enzyme helps to convert glycine into other compounds needed for normal metabolism and development. Without this enzyme, excessive amounts of glycine can build up in the bloodstream and eventually cause neurological problems.

Common symptoms of glycine encephalopathy include seizures, intellectual disability, poor muscle control, hypotonia (muscle weakness or floppiness), respiratory difficulties, hearing loss, and impaired coordination. Other signs may include delayed speech and language development, irritability or hyperactivity, difficulty swallowing, sleep disturbances or ataxia (poor coordination).

Treatment for glycine encephalopathy focuses on controlling seizures and managing any underlying medical conditions associated with it. Medications such as anticonvulsants can be used to reduce seizure activity while other therapies may be necessary to address physical impairments or developmental delays due to neurological deficits. Dietary modifications are also commonly used to reduce levels of free unmetabolized glycemic index in the blood stream where applicable. In some cases, a liver transplant may be recommended if there is significant liver disease present.